A Study on Treatment Preferences Regarding Dosage Forms of Dementia Medications in Japan.

A Study on Treatment Preferences Regarding Dosage Forms of Dementia Medications in Japan. - A Study on Treatment Preferences Regarding Dosage Forms of Dementia Medications in Japan.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061264

Enrollment

2000

Registered

2026-04-16

Start date

2026-04-20

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MCI due to Alzheimer&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants must meet all of the following conditions to be eligible for inclusion in the study: 1. Aged 40 years or older and younger than 80 years at the time of enrollment. 2. Provides informed consent to participate in the study. 3. Resides in Japan at the time of enrollment. 4. Has access to the necessary devices and a stable internet environment to complete the study online.

Exclusion criteria

Exclusion criteria: Participants who meet any of the following conditions will be excluded from the study: 1. Individuals for whom obtaining informed consent or completing the study procedures is deemed difficult due to insufficient comprehension ability, cognitive capacity, or Japanese language proficiency. 2. Individuals who are unable to personally participate in the survey.

Design outcomes

Primary

Measure	Time frame
Utility values represent the factors and preferences underlying treatment selection for mild cognitive impairment and mild dementia due to Alzheimer's disease in the general population.	—

Countries

Japan

Contacts

Public ContactMie Azuma

Eisai Co., Ltd. Japan Value and Access Department

m3-azuma@hhc.eisai.co.jp070-2474-2454

Outcome results